moaC

UniProt ID: P0A738
Organism: Escherichia coli K-12
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

MoaC is the cyclic pyranopterin monophosphate (cPMP) synthase of Escherichia coli, the second enzyme of molybdenum cofactor (Moco) biosynthesis. It receives (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate (3',8-cH2GTP), the product of the radical SAM GTP 3',8-cyclase MoaA, and catalyses the complex rearrangement that builds the pyranopterin ring and cyclic phosphate of cPMP (precursor Z), releasing diphosphate. cPMP is then converted to molybdopterin by the MoaD-MoaE molybdopterin synthase. MoaC is a small cytoplasmic protein with a ferredoxin-like fold that assembles as a homohexamer (trimer of dimers); its active site lies at the interface between two monomers, and residues such as Asp128, Lys51, His77 and Glu112 are required for activity. It is encoded in the anaerobically induced moaABCDE operon and is the bacterial counterpart of the human MOCS1B domain.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005515 protein binding
IPI
PMID:15690043
Interaction network containing conserved and essential prote...
REMOVE
Summary: Co-purification of MoaC with ribosomal protein L1 (rplA, P0A7L0) in a large-scale affinity-purification/mass-spectrometry screen.
Reason: Bare protein binding is uninformative under the protein-binding policy, and this high-throughput co-purification with an abundant ribosomal protein identifies no function of MoaC. Removal does not assert that the interaction is false; there is no more informative molecular function that this evidence supports.
Supporting Evidence:
PMID:15690043
A total of 857 proteins, including 198 of the most highly conserved, soluble non-ribosomal proteins essential in at least one bacterial species, were tagged successfully, whereas 648 could be purified to homogeneity and their interacting protein partners identified by mass spectrometry.
GO:0006777 Mo-molybdopterin cofactor biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: MoaC catalyses the second step of Moco biosynthesis, forming cPMP from 3',8-cH2GTP.
Reason: MoaC performs a catalytic step of the process (pyranopterin ring formation), so it passes the participation test. Consistent with the IMP and IDA rows and with genes/ECOLI/moaA.
Supporting Evidence:
PMID:25941396
During Moco biosynthesis, the characteristic pyranopterin ring is constructed by a complex rearrangement of guanosine 5'-triphosphate (GTP) into cyclic pyranopterin (cPMP) through the action of two enzymes, MoaA and MoaC
GO:0006777 Mo-molybdopterin cofactor biosynthetic process
IMP
PMID:25941396
Mechanism of pyranopterin ring formation in molybdenum cofac...
ACCEPT
Summary: Structure-guided mutagenesis of E. coli MoaC active-site residues abolishes cPMP formation (for example D128A, K51A, H77A and E112A).
Reason: Loss-of-function mutants of MoaC abolish the cPMP-forming step, consistent with its established biochemical role. Abstract-only cache, but the UniProt mutagenesis features cite this paper and the claim agrees with the biochemistry; deferring to the curator.
Supporting Evidence:
file:ECOLI/moaC/moaC-uniprot.txt
D->A: Complete loss of activity.
PMID:25941396
Furthermore, our structure-guided studies suggest that MoaC catalysis involves the dynamic motions of enzyme active-site loops as a way to control the timing of interaction between the reaction intermediates and catalytically essential amino acid residues.
GO:0032991 protein-containing complex
IDA
PMID:10903949
Insights into molybdenum cofactor deficiency provided by the...
KEEP AS NON CORE
Summary: The crystal structure shows that E. coli MoaC is a tightly packed homohexamer with the active site at a dimer interface.
Reason: The homohexamer is real and structurally required for the active site, but no specific GO complex term exists for a MoaC homo-oligomer, so the generic term is as precise as the evidence allows. It records quaternary structure rather than the core catalytic function.
Supporting Evidence:
PMID:10903949
The enzyme is organized into a tightly packed hexamer with 32 symmetry.
GO:0042802 identical protein binding
IDA
PMID:10903949
Insights into molybdenum cofactor deficiency provided by the...
KEEP AS NON CORE
Summary: Self-association of MoaC into a hexamer, with the active site at the interface of two monomers.
Reason: Homo-oligomerization is shown structurally and is needed to build the inter-subunit active site, but it is a structural property supporting catalysis, not the core activity.
Supporting Evidence:
PMID:10903949
Analysis of structural and biochemical data strongly suggests that the active site is located at the interface of two monomers in a pocket that contains several strictly conserved residues.
file:ECOLI/moaC/moaC-uniprot.txt
SUBUNIT: Homohexamer; trimer of dimers.
GO:0061799 cyclic pyranopterin monophosphate synthase activity
IDA
PMID:25941396
Mechanism of pyranopterin ring formation in molybdenum cofac...
ACCEPT
Summary: Purified E. coli MoaC converts 3',8-cH2GTP, the MoaA product, into cPMP; the substrate was captured in the MoaC active site.
Reason: This is the defining reaction of MoaC (EC 4.6.1.17, RHEA:49580), with kinetic parameters measured in this paper. Core function.
Supporting Evidence:
PMID:25941396
These observations provided strong evidence that the physiological function of MoaA is the conversion of GTP to 3',8-cH2GTP (GTP 3',8-cyclase), and that of MoaC is to catalyze the rearrangement of 3',8-cH2GTP into cPMP (cPMP synthase).
file:ECOLI/moaC/moaC-uniprot.txt
KM=0.21 uM for (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate
GO:0061799 cyclic pyranopterin monophosphate synthase activity
IEA
GO_REF:0000120
ACCEPT
Summary: HAMAP/Rhea mapping to the cPMP synthase reaction.
Reason: Consistent with the IDA row and the experimentally supported UniProt function.
Supporting Evidence:
file:ECOLI/moaC/moaC-uniprot.txt
FUNCTION: Catalyzes the conversion of (8S)-3',8-cyclo-7,8- dihydroguanosine 5'-triphosphate to cyclic pyranopterin monophosphate (cPMP).

Core Functions

Cyclic pyranopterin monophosphate synthase: rearranges the MoaA product 3',8-cH2GTP into cyclic pyranopterin monophosphate (precursor Z) and diphosphate, the second step of molybdenum cofactor biosynthesis, acting as a homohexamer with active sites at dimer interfaces.

Supporting Evidence:
  • PMID:25941396
    These observations provided strong evidence that the physiological function of MoaA is the conversion of GTP to 3',8-cH2GTP (GTP 3',8-cyclase), and that of MoaC is to catalyze the rearrangement of 3',8-cH2GTP into cPMP (cPMP synthase).
  • PMID:23627491
    Instead, 3β€²,8-cH2GTP is transferred to MoaC where a complex rearrangement reaction proceeds.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Is the labile 3',8-cH2GTP intermediate channelled from MoaA to MoaC in E. coli through a transient MoaA-MoaC complex, or does it diffuse freely between the enzymes?

Suggested Experiments

Experiment: Compare cPMP yields from coupled versus sequential MoaA/MoaC reactions under anaerobic conditions and test for a MoaA-MoaC complex by crosslinking or native mass spectrometry.

Hypothesis: MoaA and MoaC interact transiently to protect 3',8-cH2GTP.

πŸ“š Additional Documentation

Notes

(moaC-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)